Biocon Biologics inks settlement and license agreement to commercialize biosimilar aflibercept worldwide: Our Bureau, Bengaluru Monday, December 15, 2025, 16:45 Hrs [IST] Biocon B ...
Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced a ...
BCVA is inadequate for detecting visual disturbances in conditions like MacTel, which initially affect the parafoveal region.
Essilorluxottica (OTC) ($ESLOY) announced an update on their ongoing clinical study. Essilorluxottica is currently conducting a clinical study ...
Capital Market on MSN
Biocons arm inks pact to commercialize biosimilar Aflibercept Worldwide
As part of the agreement, all pending litigation among Biocon Biologics, Regeneron, and Bayer has been dismissed. Biocon ...
Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma, today announced new data from the investigational Phase 3 MajesTEC-3 study that demonstrate the potential of TECVAYLI® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback